Part 1: Imaging findings of common immune checkpoint inhibitor-related adverse effects
- PMID: 35244329
- DOI: 10.1111/1754-9485.13396
Part 1: Imaging findings of common immune checkpoint inhibitor-related adverse effects
Abstract
Over the last decade or so, immunotherapy and in particular immune checkpoint inhibitors have become common in the treatment of numerous cancers and have revolutionised oncology. The unique mechanisms of these agents has resulted in novel tumour response patterns and also new drug-related toxicities, both of which can have specific findings on imaging. The widespread and increasing use of these agents means these findings are now encountered across many radiology practices beyond just specialist oncology units. This pictorial essay aims to describe and illustrate imaging findings associated with common and important immune-related adverse events as a result of treatment with immune checkpoint inhibitors.
Keywords: autoimmunity; drug-related side effects and adverse reactions; immune checkpoint inhibitors; immunotherapy; medical oncology.
© 2022 Royal Australian and New Zealand College of Radiologists.
Similar articles
-
Part 2: Imaging findings of uncommon but important immune checkpoint inhibitor-related adverse effects.J Med Imaging Radiat Oncol. 2022 Jun;66(4):502-507. doi: 10.1111/1754-9485.13391. Epub 2022 Mar 1. J Med Imaging Radiat Oncol. 2022. PMID: 35233953
-
[Autoimmune side effects of immune-checkpoint inhibitor therapies in oncology: pathogenesis, clinic and treatment].Orv Hetil. 2019 Jun;160(23):887-895. doi: 10.1556/650.2019.31392. Orv Hetil. 2019. PMID: 31155880 Hungarian.
-
[Overview of immune-related side effects from immune checkpoint inhibitors. Part 1: Gastrointestinal, lung and kidney toxicity].Lakartidningen. 2021 Nov 18;118:21115. Lakartidningen. 2021. PMID: 35080767 Swedish.
-
Adverse events induced by immune checkpoint inhibitors.Curr Opin Immunol. 2021 Apr;69:29-38. doi: 10.1016/j.coi.2021.02.002. Epub 2021 Feb 25. Curr Opin Immunol. 2021. PMID: 33640598 Free PMC article. Review.
-
Management of immune checkpoint inhibitor-related dermatologic adverse events.Thorac Cancer. 2020 Feb;11(2):488-492. doi: 10.1111/1759-7714.13275. Epub 2019 Dec 9. Thorac Cancer. 2020. PMID: 31814310 Free PMC article. Review.
Cited by
-
Neuroimaging features of immune-related adverse events due to immune checkpoint inhibitor therapy.Insights Imaging. 2025 Jun 12;16(1):120. doi: 10.1186/s13244-025-01999-3. Insights Imaging. 2025. PMID: 40506672 Free PMC article.
References
-
- Kalisz KR, Ramaiya NH, Laukamp KR, Gupta A. Immune checkpoint inhibitor therapy-related pneumonitis: patterns and management. Radiographics 2019; 39: 1923-37.
-
- Wang GX, Kurra V, Gainor JF et al. Immune checkpoint inhibitor cancer therapy: spectrum of imaging findings. Radiographics 2017; 37: 2132-44.
-
- Costa LB, Queiroz MA, Barbosa FG et al. Reassessing patterns of response to immunotherapy with PET: from morphology to metabolism. Radiographics 2021; 41: 120-43.
-
- Nishino M, Hatabu H, Hodi FS. Imaging of cancer immunotherapy: current approaches and future directions. Radiology 2019; 290: 9-22.
-
- Lasocki A, Iravani A, Galligan A. The imaging of immunotherapy-related hypophysitis and other pituitary lesions in oncology patients. Clin Radiol 2021; 76: 325-32.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical